Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

P. Kühnl; M. Roggendorf; W. Sibrowski; F. Deinhardt; R. Laufs; K. Bornhövd; G. Kalmar; S. Seidl; B. O. Böhm

Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

Translated title of the contribution: Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis

P. Kühnl, M. Roggendorf, W. Sibrowski, F. Deinhardt, R. Laufs, K. Bornhövd, G. Kalmar, S. Seidl, B. O. Böhm

Universität Hamburg

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

Translated title of the contribution	Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis
Original language	German
Pages (from-to)	27-29
Number of pages	3
Journal	Beitrage zur Infusionstherapie = Contributions to infusion therapy
Volume	26
State	Published - 1990
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b001dd39bc5f4655bce4b10cd3608c1e,

title = "Hepatitis-C-Virus-Antik{\"o}rper (HCV) bei Patienten unter chronischer H{\"a}modialyse.",

abstract = "Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the {"}Eurotransplant{"} waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.",

author = "P. K{\"u}hnl and M. Roggendorf and W. Sibrowski and F. Deinhardt and R. Laufs and K. Bornh{\"o}vd and G. Kalmar and S. Seidl and B{\"o}hm, {B. O.}",

year = "1990",

language = "Deutsch",

volume = "26",

pages = "27--29",

journal = "Beitrage zur Infusionstherapie = Contributions to infusion therapy",

issn = "1011-6974",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

AU - Kühnl, P.

AU - Roggendorf, M.

AU - Sibrowski, W.

AU - Deinhardt, F.

AU - Laufs, R.

AU - Bornhövd, K.

AU - Kalmar, G.

AU - Seidl, S.

AU - Böhm, B. O.

PY - 1990

Y1 - 1990

N2 - Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

AB - Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

UR - http://www.scopus.com/inward/record.url?scp=17644443166&partnerID=8YFLogxK

M3 - Artikel

C2 - 1703848

AN - SCOPUS:17644443166

SN - 1011-6974

VL - 26

SP - 27

EP - 29

JO - Beitrage zur Infusionstherapie = Contributions to infusion therapy

JF - Beitrage zur Infusionstherapie = Contributions to infusion therapy

ER -

Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this